Population-based study on the seroprevalence of parvovirus B19 in Amsterdam

Journal of Medical Virology

Volumn 81, Issue 7, 2009, Pages 1305-1309

  Van Rijckevorsel, G G C ^a   Sonder, G J B ^a,b   Schim Van Der Loeff, M F ^a,b   Van Den Hoek, J A R ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adult population; Erythema infectiosum; Seroepidemiology; The Netherlands

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ERYTHEMA INFECTIOSUM; ETHNICITY; GROUPS BY AGE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MINORITY GROUP; NETHERLANDS; PARVOVIRUS; POPULATION RESEARCH; RANDOM SAMPLE; SEROEPIDEMIOLOGY; SEROPREVALENCE; ADOLESCENT; AGE; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; URBAN POPULATION; VIROLOGY; VIRUS INFECTION;

PARVOVIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION; YOUNG ADULT;

EID: 67649998426     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21528     Document Type: Article

References (21)

1. Agyemang C, Ujcic-Voortman J, Uitenbroek D, Foets M, Droomers M. 2006. Prevalence and management of hypertension among Turkish,Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey. J Hypertens 24:2169-2176. (Pubitemid 44611025)
2. Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA. 2007. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. JMed Virol 79:1802-1810. (Pubitemid 350006302)
3. Bhattarakosol P, Pancharoen C, Kowitdamrong E, Thammaborvorn R, Mungmee V. 2003. Prevalence of parvovirus B19 infection in Thai young adults. Southeast Asian J Trop Med Public Health 34:585-588. (Pubitemid 38068074)
4. Bosman A, Wallinga J, Kroes ACM. 2002. Fifth disease every four years; parvovirus B19. Infectieziekten Bull 13:215-219.
5. Cohen BJ, Buckley MM. 1988. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25:151-153.
6. Cohen BJ, Kumar S. 2005. Parvovirus B19 infection in pregnancy. Fetal Matern Med Rev 16:123-150.
7. Heegaard ED, Brown KE. 2002.HumanparvovirusB19. Clin Microbiol Rev 15:485-505.
8. van Gessel PH, Gaytant MA, Vossen AC, Galama JM, Ursem NT, Steegers EA, Wildschut HI. 2006. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study. Eur J Obstet Gynecol Reprod Biol 128:46-49. (Pubitemid 44311331)
9. Mossong J, Hens H, Friederichs V, Davidkin I, Broman M, Litwinska B, Siennicka J, Trzcinska A, Damme P, van Beutels P, Vyse A, Shkedy Z, Aerts M, Massari M, Gabutti G. 2007. Parvovirus B19 infection in five European countries: Seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 136: 1059-1068.
10. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. 2000. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 124:449-457. (Pubitemid 30623862)
11. Knowles SJ, Grundy K, Cahill I, Cafferkey MT. 2004. Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health 7:344-348.
12. Kramer M, Uitenbroek D, Ujic-Voortman J, Pfrommer C, Spaargaren J, Countinho RA, Dukers-Muijrers N. 2008. Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, The Netherlands. Euro Surveill 13 pii:18904.
13. Leikin E, Figueroa R, Bertkau A, Lysikiewicz A, Visintainer P, Tejani N. 1997. Seronegativity to varicella-zoster virus in a tertiary care obstetric population. Obstet Gynecol 90:511-513. (Pubitemid 27407387)
14. Lin KH, You SL, Chen CJ, Wang CF, Yang CS, Yamazaki S. 1999. Seroepidemiology of human parvovirus B19 in Taiwan. JMed Virol 57:169-173. (Pubitemid 29022510)
15. Ooi SL, Hooi PS, Chua BH, Lam SK, Chua KB. 2002. Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia. Med J Malaysia 57:97-103.
16. Poovorawan Y, Theamboonlers A, Suandork P, Hirsch P. 2000. Prevalence of antibodies to parvovirus B 19 in Thailand. Southeast Asian J Trop Med Public Health 31:422-424.
17. Röhrer C, Gartner B, Sauerbrei A, Bohm S, Hottentrager B, Raab U, Thierfelder W, Wutzler P, Modrow S. 2008. Seroprevalence of parvovirus B19 in the German population. Epidemiology and Infection 16:1-12. Published online by Cambridge University Press 16 Jan 2008. 10.1017/S0950268807009958.
18. Schwarz TF, Gurtler LG, Zoulek G, Deinhardt F, RoggendorfM. 1989. Seroprevalence ofhuman parvovirus B19 infection in SaoTome and Principe, Malawi and Mascarene Islands. Zentralbl Bakteriol 271:231-236.
19. Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, Aaby P, Pedersen BN, Melbye M. 1999. Risk factors for parvovirus B19 infection in pregnancy. J Am Med Assoc 281: 1099-1105. (Pubitemid 29155886)
20. Vyse AJ, Andrews NJ, Hesketh LM, Pebody R. 2007. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 135:1354-1362. (Pubitemid 351148097)
21. Zaaijer HL, Koppelman MH, Farrington CP. 2004. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 132:1161-1166 (Pubitemid 39642399)